Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated with Zolgensma® (onasemnogene abeparvovec)

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing